Interestingly, additional inclusion of serum cystatin C ≥ 0.97 mg/L in the model significantly improved the diagnostic accuracy for poor coronary collateralization in all subgroup population based on age, gender, presence or absence of diabetes, hypertension, or at least mild renal dysfunction by 8.0–18.2%. The gene discussed is CST3; the disease is Hypertension.